Results of cervical cancer trial hailed as 'biggest breakthrough for decades'

14 October 2024

Findings from a CTC-led study into cervical cancer treatment have been published in the Lancet today, prompting further coverage for a trial which first caught the attention of the public last year.

Results for the INTERLACE trial have shown a course of treatment with existing drugs prior to chemoradiation led to a 35% reduction in the risk of death or return of cancer.

The results were first presented to the public at the ESMO conference last October. More information can be read in our article at the time.

The CTC media team interviewed the trial's CI, one of its patients, and one of the statisticians responsible for deciphering the results. The article was published as part of UCL's digital campaign for World Cancer Day this year.

External links

The Lancet | INTERLACE paper

The Guardian | New cervical cancer treatment regime 'cuts risk of dying from disease by 40%'

The Times | New treatment regimen cuts cervical cancer deaths by 40%

Sky News | Simple tweak to cervical cancer treatment cuts risk of death by 40%, say researchers

The Independent | Treatment cuts cervical cancer deaths by 40% in 'biggest breakthrough for decades'

Cancer Research UK | Cervical cancer treatment breakthrough cuts risk of death by 40%

More news articles

(Publication) High-Dose Methotrexate in Children and Young Adults With ALL and Lymphoblastic Lymphoma: Results of the Randomized Phase III Study UKALL 2011

Kirkwood AA, Goulden N, Moppett J, Samarasinghe S, Hough R, Rowntree C, Lawson S, Kearns P, Lawson A, Vora A.

(Publication) Induction chemotherapy followed by chemoradiation in locally advanced cervical cancer: Quality of life outcomes of the GCIG INTERLACE trial

G. Eminowicz, S. Vaja, D. Gallardo, C. Kent, M. Panades, T. Mathew, A. Anand, J. Forrest, M. Adusumalli, A. Chan, A.M. Hacker, A. Hackshaw, [...]

(Publication) Risk factors for CAR T-cell manufacturing failure and patient outcomes in large B-cell lymphoma: a report from the UK National CAR T Panel

Dulobdas V, Kirkwood AA, Serpenti F, Gautama B, Panopoulou A, Mathew A, Gabriel S, Malladi R, Pealing J, Bonney D, Nicholson E, Besley C, Gh [...]

UCL marks World Cancer Day, CTC work highlighted

Today marks World Cancer Day, an annual initiative which takes place every 4 February to raise awareness of cancer, helping in turn to impro [...]

Cancer Research UK & UCL Cancer Trials Centre
University College London
90 Tottenham Court Road
London
W1T 4TJ

View map

Email:
ctc.enquiries@ucl.ac.uk
Telephone:
+44 (0)20 7679 9898 (General CTC Enquiries)
Fax:
020 7679 9899

CTC staff

University College London, Gower Street, London, WC1E 6BT +44 (0)20 7679 2000